Key Points
- Omada Health CEO Sean Duffy sold 14,158 shares on June 26 at an average price of $20.00, totaling about $283,160. After the sale, he still owned 394,603 shares worth about $7.89 million.
- The company recently beat earnings expectations by reporting EPS of -$0.05 versus the expected -$0.08, on revenue of $78.05 million for the quarter.
- Wall Street remains cautiously positive on Omada Health, with a consensus rating of “Moderate Buy” and an average price target of $22.91, while shares recently traded at $20.89.
Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) CAO Craig Gracey sold 2,083 shares of the stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $19.01, for a total value of $39,597.83. Following the completion of the sale, the chief accounting officer owned 5,025 shares of the company's stock, valued at $95,525.25. The trade was a 29.31% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
Craig Gracey also recently made the following trade(s):
- On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $18.00, for a total value of $37,494.00.
- On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The shares were sold at an average price of $17.42, for a total transaction of $120,093.48.
Omada Health Trading Up 10.5%
Shares of NASDAQ:OMDA opened at $20.89 on Friday. The firm has a market cap of $1.24 billion and a price-to-earnings ratio of -77.37. Omada Health, Inc. has a 1 year low of $10.28 and a 1 year high of $26.92. The business has a fifty day simple moving average of $16.51 and a 200 day simple moving average of $14.85.
Omada Health (NASDAQ:OMDA - Get Free Report) last announced its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, topping analysts' consensus estimates of ($0.08) by $0.03. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%.The company had revenue of $78.05 million during the quarter. On average, sell-side analysts forecast that Omada Health, Inc. will post -0.01 EPS for the current year.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of the business. Raymond James Financial Inc. bought a new stake in shares of Omada Health during the second quarter worth $32,000. Quarry LP acquired a new position in Omada Health during the 4th quarter worth about $29,000. TD Waterhouse Canada Inc. bought a new stake in Omada Health during the 4th quarter worth about $32,000. Inlight Wealth Management LLC acquired a new stake in Omada Health in the 4th quarter valued at about $45,000. Finally, JPMorgan Chase & Co. acquired a new stake in Omada Health in the 3rd quarter valued at about $82,000.
Analyst Upgrades and Downgrades
Several research analysts have recently issued reports on OMDA shares. Canaccord Genuity Group set a $24.00 price objective on shares of Omada Health in a report on Friday, May 8th. Wells Fargo & Company lifted their target price on Omada Health from $17.00 to $18.00 and gave the stock an "equal weight" rating in a research report on Friday, May 8th. Evercore restated an "outperform" rating and set a $20.00 price target on shares of Omada Health in a research note on Friday, May 8th. The Goldman Sachs Group reaffirmed a "buy" rating on shares of Omada Health in a report on Friday, May 8th. Finally, Citigroup reiterated an "outperform" rating on shares of Omada Health in a research report on Friday, May 8th. Ten equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $22.91.
Get Our Latest Stock Report on OMDA
Omada Health Company Profile
(
Get Free Report)
Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.
In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
